⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

July 25, 2024AntibioticsOpen Access

Adverse Events Comparison of Double Beta-Lactam Combinations for Bloodstream Infections: Ampicillin plus Ceftriaxone and Ampicillin/Cloxacillin

Kazuhiro Ishikawa Daiki Kobayashi Nobuyoshi Mori

View Full Paper

Ask AI

Bookmark

Share

Abstract

In Japan, only ampicillin/cloxacillin (ABPC/MCIPC) is available as an anti-staphylococcal penicillin-based treatment for

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Ishikawa et al. (2024) studied this question.

synapsesocial.com/papers/68e5f1bab6db6435875866f0 https://doi.org/10.3390/antibiotics13080696

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1The comparison of adverse events in combination with double beta-lactam antimicrobials: Ampicillin plus Ceftriaxone and Ampicillin/Cloxacillin with bloodstream infections.2024
2P-664. Comparison of Ceftriaxone vs. Ampicillin Sulbactam for the Treatment of Community Acquired PneumoniaCohort Study · 2026
3Cephalotin Versus Dicloxacillin for the Treatment of Methicillin-Susceptible Staphylococcus aureus Bacteraemia: A Retrospective Cohort Study2024 · 3 citations
4Is ampicillin plus cephalosporins a therapeutic option for Ampicillin-Susceptible <i>Enterococcus faecium</i>?2025
5Benzylpenicillin versus flucloxacillin or cloxacillin for the treatment of penicillin-susceptible Staphylococcus aureus bacteraemia (SNAP): an international, multicentre, open-label, non-inferiority randomised controlled trialRCT · 2026 · 3 citations